Breaking News

Tweet TWEET

Orion Oyj : 700,000 Orion A-shares converted into B-shares

          Orion Oyj : 700,000 Orion A-shares converted into B-shares




ORION CORPORATION    STOCK EXCHANGE RELEASE 19 APRIL 2013 at 09.20 a.m.
EEST       

In accordance with Section 3 of the Articles of Association of Orion
Corporation, 700,000 A-shares have been converted into 700,000 B-shares. The
conversion has been entered into the Trade Register on 19April 2013.

The total number of shares in Orion Corporation is 141,257,828 which, after
the conversion, consists of 42,535,318 A-shares and 98,722,510 B-shares.


Orion Corporation

Olli Huotari              Jari Karlson
SVP, Corporate Functions  CFO

           

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. Pharmaceutical R&D focuses on central nervous
system drugs, oncology and critical care drugs, and Easyhaler® pulmonary
drugs.

Orion's net sales in 2012 amounted to EUR 980 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX
Helsinki.

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Orion Oyj via Thomson Reuters ONE
HUG#1694382
 
Press spacebar to pause and continue. Press esc to stop.